Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

NEPTUNE I and II data on tamsulosin/solifenacin presented

Oct. 22, 2012

Phase II and III studies of bardoxolone methyl suspended

Oct. 19, 2012

Researchers describe activity of TAC-302

Oct. 19, 2012

Mitsubishi Tanabe and Kureha complete EPPIC phase III studies

Oct. 10, 2012

Encouraging follow-up data emerges from phase IIb PRX-302 study

Oct. 10, 2012

AstraZeneca and Ardelyx sign licensing deal for NHE-3 inhibitor program

Oct. 10, 2012

Mirabegron safe in male patients with bladder outlet obstruction

Oct. 8, 2012

Bayer Yakuhin seeks additional approval for Fosrenol chewable tablets and granules in Japan

Oct. 5, 2012

Votubia recommended for approval in Europe

Sep. 26, 2012

CHMP gives positive opinion on Cialis in new indication

Sep. 26, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...